Seres Therapeutics Inc (1S9) : Analyse, Valorisation, Dividende et Ratios Financiers

Seres Therapeutics Inc

1S9StockF

€—

1

Seres Therapeutics Inc

€—

1S9StockF

Arberion© 2026

Arberion

Loading market data